TAYLOR AGATE: Open Payments
NPI 1871196477 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$979 in 34 payments from 14 companies in 2025. Trend: 2023 $44 · 2024 $502 · 2025 $979
Food & beverage: $879Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 6 | $197 |
| GENZYME CORPORATION | 5 | $163 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $140 |
| Incyte Corporation | 4 | $113 |
| LEO Pharma Inc. | 3 | $72 |
| PFIZER INC. | 3 | $69 |
| Botanix SB Inc | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $34 |
| ABBVIE INC. | 1 | $31 |
Products named: Bimzelx, DUPIXENT, OPZELURA, ADBRY, CIBINQO, SOFDRA, ILUMYA, LIBTAYO.
Industry payments across IL — which companies pay providers there.
